Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucillia Bezu

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Medicina (Kaunas, Lithuania)|August 29, 2024
Impact of Surgical and Anesthetic Procedures after Colorectal Cancer Surgery: A Propensity Score-Matched Cohort Study (The PROCOL Study)Céline Kuoch, Lucillia Bezu
Oncoimmunology|November 22, 2024
High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapyLucillia Bezu, Guido Kroemer
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2021
Calreticulin Exposure in Mitotic CatastropheLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|May 23, 2022
Immunogenic stress induced by local anesthetics injected into neoplastic lesionsLucillia Bezu, Oliver Kepp, Guido Kroemer
Frontiers in Oncology|September 16, 2022
Impact of local anesthetics on epigenetics in cancerLucillia Bezu, Oliver Kepp, Guido Kroemer
Seminars in Immunopathology|August 31, 2022
Local anesthetics and immunotherapy: a novel combination to fight cancerLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|August 1, 2025
Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidineLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|June 27, 2022
The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?Oliver Kepp, Lucillia Bezu, Guido Kroemer
Oncoimmunology|December 21, 2023
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitorsLucillia Bezu, Oliver Kepp, Guido Kroemer
Molecular & Cellular Oncology|September 18, 2020
EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell deathJuliette Humeau, Lucillia Bezu, Oliver Kepp, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Medicina (Kaunas, Lithuania)|August 29, 2024
Impact of Surgical and Anesthetic Procedures after Colorectal Cancer Surgery: A Propensity Score-Matched Cohort Study (The PROCOL Study)Céline Kuoch, Lucillia Bezu
Oncoimmunology|November 22, 2024
High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapyLucillia Bezu, Guido Kroemer
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2021
Calreticulin Exposure in Mitotic CatastropheLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|May 23, 2022
Immunogenic stress induced by local anesthetics injected into neoplastic lesionsLucillia Bezu, Oliver Kepp, Guido Kroemer
Frontiers in Oncology|September 16, 2022
Impact of local anesthetics on epigenetics in cancerLucillia Bezu, Oliver Kepp, Guido Kroemer
Seminars in Immunopathology|August 31, 2022
Local anesthetics and immunotherapy: a novel combination to fight cancerLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|August 1, 2025
Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidineLucillia Bezu, Oliver Kepp, Guido Kroemer
Oncoimmunology|June 27, 2022
The endoplasmic reticulum chaperone BiP: a target for immunogenic cell death inducers?Oliver Kepp, Lucillia Bezu, Guido Kroemer
Oncoimmunology|December 21, 2023
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitorsLucillia Bezu, Oliver Kepp, Guido Kroemer
Molecular & Cellular Oncology|September 18, 2020
EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell deathJuliette Humeau, Lucillia Bezu, Oliver Kepp, et al.
Pageof 6